In an April 19 report, JCR
kept its BBB+ credit rating on the Philippines, but raised the outlook to 'positive' from 'stable' previously.
As of November 2018, JCR
has aggregated data from over 11,500 titles and over 230 disciplines.
Walker & Dunlop Inc (NYSE:WD) revealed on Wednesday that its alternative investment management platform and wholly owned subsidiary, JCR
Capital closed on its fourth fund, JCR
Capital Income Plus Fund IV LP (Fund IV), at USD306m.
After 18 months of evaluating Class A office buildings, Regency Towers retained JCR
as an anchor tenant.
White will take up the role and be responsible for the performance of all three of JCR
's North West racecourses, based at Haydock Park.
With over USD 800 million in assets under management, JCR
has a strong track record investing institutional capital in commercial real estate including joint venture equity, preferred equity, mezzanine debt, and transitional first-trust loans.
integrates improved Force XXI Battle Command Brigade and Below (FBCB2) and Blue Force Tracking (BFT) capabilities into the existing MTS hardware in order to standardize the software used by the Army's ground forces.
The company's profit level and capital adequacy remain generally flat but improvement is still possible, according to JCR
. The rater advises BOT Lease to try to recover the amount of contracts concluded while retaining its profitability.
However, Thick and White, both leading lights within the old JCR
structure, were believed to have been in the running to replace Edward Gillespie as chief executive at Cheltenham - a prestigious role that went to former Arena Leisure managing director Ian Renton, along with an extended brief encompassing Warwick, Exeter and Wincanton - and may not be placed for reduced roles within the new JCR
system, although the decisions are said not yet to have been made.
The company says under the terms of the collaboration, JCR
will bear all costs associated with bringing the drug to market in Japan.
Tokyo, Japan, Dec 27, 2005 - (JCN) - Kissei Pharmaceutical and JCR
Pharmaceuticals have jointly announced that they have singed a joint research agreement for JR-013, a compound candidate discovered by JCR